The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Mergers & AcquisitionsMedium•25 June 2026•

1 min read

Agilent Technologies Completes Biocare Medical Acquisition

Key Facts

1Agilent Technologies has completed its acquisition of Biocare Medical, a leader in clinical pathology.

Agilent Technologies has completed its acquisition of Biocare Medical, a leader in clinical pathology, according to a Business Wire report. The acquisition is part of the company's strategy to expand its pathology offerings.

The company expects the acquisition to be accretive to growth, margins, and non-instrument revenue within 12 months, per the announcement. Agilent shares closed at $131.63 on June 24, 2026, with a daily range of $128.25–$132.72. Investors will monitor integration progress and the impact on quarterly results as the company leverages Biocare's clinical pathology expertise.